APA (7th ed.) Citation

M, E., R, J., & T, R. (2026). Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis. Multiple sclerosis journal - experimental, translational and clinical, 12(1), 20552173261432453. https://doi.org/10.1177/20552173261432453

Chicago Style (17th ed.) Citation

M, Elkhooly, Jacob R, and Rempe T. "Safety and Efficacy of Extended Versus Standard Interval Dosing of Anti-CD20 Therapy in Multiple Sclerosis - A Meta-analysis." Multiple Sclerosis Journal - Experimental, Translational and Clinical 12, no. 1 (2026): 20552173261432453. https://doi.org/10.1177/20552173261432453.

MLA (9th ed.) Citation

M, Elkhooly, et al. "Safety and Efficacy of Extended Versus Standard Interval Dosing of Anti-CD20 Therapy in Multiple Sclerosis - A Meta-analysis." Multiple Sclerosis Journal - Experimental, Translational and Clinical, vol. 12, no. 1, 2026, p. 20552173261432453, https://doi.org/10.1177/20552173261432453.